German Hodgkin's Lymphoma Study Group Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2001
NCT00025636
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now